Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amatto VC"'
Autor:
Chaudhuri N; Faculty of Life and Health Sciences, School of Medicine, Ulster University, Magee Campus, Londonderry, UK. nazia.chaudhuri@nhs.net., Spagnolo P; Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy., Valenzuela C; ILD Unit, Pulmonology Department, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain., Amatto VC; TA Inflammation Med, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Carter OT; Adelphi Real World, Bollington, UK., Lee L; Adelphi Real World, Bollington, UK., Small M; Adelphi Real World, Bollington, UK., Kreuter M; Mainz Center for Pulmonary Medicine, Department of Pneumology ZfT, Department of Pulmonary, Critical Care & Sleep Medicine, Mainz University Medical Center, Marienhaus Clinic Mainz, Mainz, Germany. Michael.Kreuter@marienhaus.de.
Publikováno v:
Respiratory research [Respir Res] 2024 Oct 09; Vol. 25 (1), pp. 364. Date of Electronic Publication: 2024 Oct 09.
Autor:
Maltais F; Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC, Canada. Electronic address: Francois.Maltais@fmed.ulaval.ca., Buhl R; Pulmonary Department, Mainz University Hospital, Mainz, Germany., Koch A; Medizinische Klinik und Poliklinik V, Klinikum der Ludwig-Maximilians-Universität, and the German Center for Lung Research (DZL), Klinikum der Ludwig-Maximilians-Universität, Munich, Germany., Amatto VC; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Reid J; Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Grönke L; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Bothner U; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Voß F; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., McGarvey L; Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI.
Publikováno v:
Chest [Chest] 2018 Jun; Vol. 153 (6), pp. 1315-1325. Date of Electronic Publication: 2018 Jan 31.
Autor:
Raghu G; Division of Pulmonary & Critical Care Medicine, University of Washington, Seattle, WA, USA graghu@uw.edu., Amatto VC; TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany., Behr J; Medizinische Klinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany., Stowasser S; TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
Publikováno v:
The European respiratory journal [Eur Respir J] 2015 Oct; Vol. 46 (4), pp. 1113-30.
Autor:
Aalbers R; Department of Pulmonary Disease, Martini Hospital, Groningen, The Netherlands. R.Aalbers@MZH.NL., Maleki-Yazdi MR; Division of Respiratory Medicine, Women's College Hospital, University of Toronto, Toronto, ON, Canada., Hamilton A; Boehringer Ingelheim, Burlington, ON, Canada., Waitere-Wijker S; Boehringer Ingelheim BV, Alkmaar, The Netherlands., Zhao Y; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Amatto VC; Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim, Germany., Schmidt O; Lungen- und Bronchialheilkunde, Koblenz, Germany., Bjermer L; Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund, Sweden.
Publikováno v:
Advances in therapy [Adv Ther] 2015 Sep; Vol. 32 (9), pp. 809-22. Date of Electronic Publication: 2015 Sep 24.